Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation

Paclitaxel is a chemotherapeutic drug commonly used to treat different types of cancer. In addition to its antitumor effect, paclitaxel is also known to promote Toll-like receptor (TLR) 4-dependent inflammatory responses, which may lower its chemotherapeutic efficacy. However, it remains unclear whe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Son, Seunghwan, Shim, Do-Wan, Hwang, Inhwa, Park, Jong-Hwan, Yu, Je-Wook
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6532018/
https://ncbi.nlm.nih.gov/pubmed/31156650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01108
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller